USPTO serial 97842014
HEMAVANT
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- SANGID, HANA RONNY
- Law office
- TMO LAW OFFICE 128
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HEMAVANT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joyce M. Ferraro
Joyce M. Ferraro FROSS ZELNICK LEHRMAN & ZISSU, P.C.151 WEST 42ND STREET, 17TH FLOORNEW YORK, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for human use for the treatment of hematological and bleeding diseases, disorders and conditions; biologic preparations for medical and therapeutic purposes for the treatment of hematological and bleeding diseases, disorders and conditions | ACTIVE | — |
| 042 | Scientific and technological services, namely, medical research, scientific research and analysis in the field of hematology and bleeding diseases, disorders and conditions pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; Conducting clinical trials for others relating to pharmaceutical preparations and biologic preparations; conducting post-authorization pharmaceutical research for use in the marketing of pharmaceutical preparations and biologic preparations and evaluating epidemiological results | ACTIVE | — |
| 044 | Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 7, 2024 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Aug 7, 2024 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jul 30, 2024 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jul 30, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 30, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 30, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 30, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 16, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jan 16, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Oct 17, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 17, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 17, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 31, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 7, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 6, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 20, 2023 | NWAP | NEW APPLICATION ENTERED | — |